-
August 23, 2011
Glaxo HPV vaccine protects women from anal cancer
CHICAGO (Reuters) - A vaccine to prevent cervical cancer offered strong protection against anal cancer in a large study of women in Costa Rica, adding to evidence that such vaccines can protect against more than just cervical cancer, U.S. researchers said on Monday.
-
August 23, 2011
Glaxo HPV vaccine protects women from anal cancer
CHICAGO (Reuters) - A vaccine to prevent cervical cancer offered strong protection against anal cancer in a large study of women in Costa Rica, adding to evidence that such vaccines can protect against more than just cervical cancer, U.S. researchers said on Monday.
-
December 22, 2010
Merck's Gardasil wins US approval for anal cancer
NEW YORK (Reuters) - Merck & Co's Gardasil vaccine won U.S. approval on Wednesday for preventing anal cancer, providing a new weapon against a rare but rising form of the disease.
-
November 17, 2010
US panel positive on Merck vaccine for anal cancer
SILVER SPRING, Md. (Reuters) - Merck & Co's Gardasil vaccine appears effective for preventing anal cancer, members of a U.S. advisory panel said on Wednesday.
-
April 22, 2008
Cisplatin not effective in anal cancer: study
CHICAGO (Reuters) - Treating anal cancer patients with the cancer-fighting drug cisplatin to try to shrink tumors before beginning standard therapy did not boost survival rates, and is not recommended, U.S. researchers said on Tuesday.